CTRI/2023/04/051549尚未招募Unknown
Randomized open label controlled clinical trial to evaluate an effect of Jivanti Ghrita eye drops in Dry Eye syndrome.
Center for Research and Development0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Gharsha(Foreign body sensation),
- •Samdahan(Burning),
- •Upadeha(Mucous discharge),
- •Avil Darshana(Blurring of vision), Vishushkatva(Dryness),
- •Toda,Bhed,Shool( Pain),
- •Kunita Vartma(Narrowing of Palpebral aperture due to Photophobia).
排除标准
- •Patient presenting with dry eye complicated with infective conjunctivitis.
- •Patient presenting with disorders of lid-globe apposition.
- •Patient suffering from specific ocular or systemic diseases
研究者
相似试验
已完成
4 期
Evaluation of the effect of Allopurionol on the progression of Chronic Kidney Disease of Uncertain etiology in Sri LankaChronic Kidney Disease of uncertain etiology (CKD-u)SLCTR/2017/026ational Research Council, Sri Lanka
尚未招募
2 期
Study the effect of Ayurvedic formulation in kidney stoneCTRI/2023/11/060093Ayurved Seva Sangh Ayurved Mahavidyalaya
进行中（未招募）
1 期
The efficacy and the safety of Vitamin D3 30,000 IU for loading dose schedulesVitamin-D deficient patientsMedDRA version: 20.0Level: PTClassification code 10047626Term: Vitamin D deficiencySystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2018-000508-40-HUPharma Patent Kft.96
已完成
2 期
An open label Randomized Controlled Clinical trial to Evaluate the Safety and Efficacy of selected Siddha formulations in patients diagnosed with COVID-19CTRI/2020/06/025768ational Institute of Siddha215
进行中（未招募）
1 期
Clinical Trial of vedolizumab versus conventional treatment for Checkpoint Inhibitor induced ColitisImmune check point inhibitor induced colitisMedDRA version: 22.0Level: LLTClassification code 10082455Term: Immune-mediated colitisSystem Organ Class: 100000004856EUCTR2020-005793-10-DKJakob Benedict Seidelin76